Company Filing History:
Years Active: 2022
Title: Santhi Gorantla: Innovator in Biomedical Research
Introduction
Santhi Gorantla is a notable inventor based in Omaha, Nebraska, recognized for his contributions to biomedical research. His innovative work focuses on the development of non-human animals that possess human interleukin-34 (IL-34), which has significant implications for medical research and therapies.
Latest Patents
Santhi Gorantla holds a patent titled "Non-human animal having human IL-34 and use Thereof." This invention provides a non-human animal that contains human IL-34 in its body. The patent also outlines methods for producing such animals, including the transplantation of human CD34-positive hematopoietic stem cells. Additionally, it describes a method for obtaining human microglia from these specially engineered animals.
Career Highlights
Throughout his career, Santhi Gorantla has worked with esteemed institutions such as the Central Institute for Experimental Animals and the University of Nebraska. His research has contributed to advancements in understanding human diseases and potential treatments.
Collaborations
Santhi has collaborated with notable colleagues, including Larisa Poluektova and Mamoru Ito, who have contributed to his research endeavors.
Conclusion
Santhi Gorantla's innovative work in creating non-human animals with human IL-34 showcases his commitment to advancing biomedical research. His contributions are paving the way for new therapeutic approaches in medicine.